Rare diseases
Investigational molecules
Locations
Study of oral rilzabrutinib for adults with immune thrombocytopenia who did not respond to first-line treatment
FranceStudy of trastuzumab deruxtecan with pembrolizumab versus platinum chemotherapy with pembrolizumab for patients with untreated HER2-positive non-small cell lung cancer
FranceLong-term safety and effectiveness study of ritlecitinib in children with severe alopecia areata who completed previous trials B7981027 or B7981031
FranceA study of LTP001 in combination with standard treatment for adults with pulmonary arterial hypertension
FranceStudy of bedaquiline, pretomanid, linezolid and moxifloxacin combination treatment for patients with multidrug-resistant tuberculosis in France
FranceStudy comparing standard and reduced intensity treatment in patients with acute myeloid leukemia or chronic lymphocytic leukemia who have no detectable disease after initial therapy
FranceStudy of etentamig and iberdomide treatment for patients with relapsed or refractory multiple myeloma
FranceStudy of olverembatinib with chemotherapy versus standard therapy in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
FranceStudy of Tarlatamab and Temozolomide combination treatment in adolescents and adults with high grade brain tumors
FranceStudy comparing tadalafil with ambrisentan versus tadalafil alone in newly diagnosed patients with pulmonary arterial hypertension who have cardiovascular conditions
FranceStudy comparing remibrutinib and ocrelizumab in patients with relapsing multiple sclerosis who switch from ocrelizumab treatment
FranceStudy of Obinutuzumab treatment for patients with non-infectious cryoglobulinemia vasculitis who did not respond to or cannot tolerate Rituximab
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
